PMCTPharmaCountry
    홈

규제 업데이트

FDA, EMA, TGA 및 글로벌 규제 동향

#Ranitidine ×

UPDATED
규제 업데이트
2026년 9월 17일•1분 읽기
FDA Approves ANDA077824 for Ranitidine Tablets by Amneal Pharmaceuticals
The FDA has granted approval for ANDA077824, authorizing Amneal Pharmaceuticals’ oral ranitidine tablets in 150 mg and 300 mg strengths, now listed as discontinued.
UPDATED
규제 업데이트
2026년 8월 30일•1분 읽기
FDA Approves Ranitidine Oral Syrup (ANDA077405)
The FDA has granted approval for ANDA077405, an oral Ranitidine hydrochloride syrup (15 mg/ml) manufactured by Pharmaceutical Associates, Inc., with labeling updates through 2010.
2